Special Populations (SPO) Community

The Special Populations Community focuses on research with groups of patients that differ with regard to human development (pediatrics, geriatrics, pregnancy), gender, ethnicity, socioeconomic status, body condition (obesity/malnutrition), or lifestyle (drug dependence, smoking).

Community Mission

The mission of the Special Populations Community is to engage members in clinical pharmacology and translational medicine research across academia, regulatory agencies, and industry to understand factors that contribute to variable therapeutic outcomes in special populations.

Community Goals

  • Provide a Community environment that fosters the development of much needed scientific expertise in special populations, including an appreciation for the diversity of the research in special populations.
  • Encourage the development of innovative pharmacological tools to engage special populations in research.
  • Stimulate scientific collaborations among clinical pharmacologists with interests in special populations and encourage the sharing of knowledge about common challenges in conducting research in special populations.
  • Provide a platform to collaborate with regulatory agencies to disseminate knowledge and expertise for the enhancement of guidelines on special populations.
  • Support members to propose and sponsor programming for ASCPT Annual Meetings as well as webinars and other educational resources throughout the year that are of interest to the SPO Community.
  • Encourage feedback from the SPO Community members and be responsive to ideas, initiatives, and involvement.
Like on Facebook Join the LinkedIn Group

Upcoming Webinar
ASCPT Webinar presented by the Special Populations (SPO) Community and Regulatory Science (RS) Community
Title:  Pediatric Master Protocols: Clinical Pharmacology Challenges and Opportunities
Date and Time: Monday, October 7, 2019, 1:00 pm ET
Speakers and Panelists: Luna Musib, PhD, Elimika Pfuma Fletcher, PharmD, PhD, and Nita Seibel, MD
Moderators: Anuradha Ramamoorthy, PhD
Description: This special session will focus on opportunities, considerations and challenges related to pediatric master protocols. The speakers will discuss pharmacogenomic and other clinical pharmacology considerations for master protocols. Examples of pediatric master protocols will be highlighted. The pharmacogenomic discussion will highlight considerations for patient selection and treatment allocation based on molecular subsets of disease. The session will also include a moderated panel discussion, including a clinician involved in the NCI Pediatric MATCH trial.
Registration Link: 

Past Webinars

Bianca van Groen, PharmD

Community Chair


Violette Gijsen, MsC, PhD, MD

Community Vice Chair


Pooja Manchandani, PhD

Community Vice Chair


Paulien Ravenstijn, PhD

Community Past Chair


SPO Steering Committee
Akshanth Polepally, PhD
Erica Woodahl, PhD
Malaz AbuTarif, PhD
Elimika Fletcher, PharmD, PhD
Kit Wun Kathy Cheung, PharmD
Manoranjenni Chetty, PhD
David Hahn, PhD
Stephani Stancil, PhD
Anh Duong, PharmD
Benjamin Weber, PharmD, PhD
Farzaneh Salem, PharmD, PhD
Photo Gallery
Recent News
Contact Us